Opioid Overdose Treatment Market is segmented By Drug Class (Methadone, Naltrexone, Buprenorphine), By Route of Administration (Oral, Parenteral), By ....
Market Size in USD
CAGR6.1%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 6.1% |
Market Concentration | High |
Major Players | Enalare Therapeutics Inc., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Emergent BioSolutions, Purdue Pharma |
The Global Opioid Overdose Treatment Market is estimated to be valued at USD 45.9 Bn in 2024 and is expected to reach USD 68.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031. This market encompasses both prescription and illicit opioids which have led to a rise in overdose deaths in recent years. The growing elderly population which is more likely to be prescribed opioid painkillers for chronic pain conditions is expected to drive increased demand. Additionally, greater awareness and availability of naloxone which can reverse opioid overdoses will spur market growth as these drugs are more widely adopted.
An opioid overdose occurs when a person consumes too much of an opioid drug, leading to life-threatening symptoms such as slowed or stopped breathing, unconsciousness, and potentially death. Common opioids include prescription painkillers like oxycodone and illegal drugs like heroin. Immediate medical intervention, including naloxone, can reverse an overdose. The market is expected to witness the rise in prescription for opioids particularly synthetic opioids such as fentanyl. Increasing street availability of illicit fentanyl and fentanyl analogs will worsen the epidemic according to the CDC. However, greater prevention efforts and enforcement against illicit manufacturing and distribution networks may help curb non-medical use which can offset some of the projected growth.